Housman Tamara Salam, Rohrback Janelle M, Fleischer Alan B, Feldman Steven R
Bristol-Myers Squibb Center for Dermatology Research, and Department of Dermatology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071, USA.
J Am Acad Dermatol. 2002 Apr;46(4):557-9. doi: 10.1067/mjd.2002.120451.
Phototherapy is an established treatment modality for psoriasis. The use of phototherapy for psoriasis appears to be in decline in nonfederal and non-university-based settings. We used data from the National Ambulatory Medical Care Survey to estimate the number of visits for phototherapy and psoralen ultraviolet A-range (PUVA) light therapy from 1993 to 1998. There were 873,000 visits for UV light therapy in 1993-1994, 189,000 in 1995-1996, and 53,000 in 1997-1998 (P <.0001). There were 175,000 psoralen visits in 1993-1994, 61,000 in 1995-1996, and 25,000 in 1997-1998 (P =.0053). Similar decreases in phototherapy visits occurred in our university-based practice. The decline in phototherapy represents decreased utilization of a safe and effective treatment for psoriasis.
光疗是一种已确立的银屑病治疗方式。在非联邦和非大学背景的医疗机构中，光疗在银屑病治疗中的使用似乎呈下降趋势。我们利用国家门诊医疗调查的数据来估算1993年至1998年期间光疗和补骨脂素紫外线A光疗法（PUVA）的就诊次数。1993 - 1994年有87.3万次紫外线光疗就诊，1995 - 1996年为18.9万次，1997 - 1998年为5.3万次（P <.0001）。1993 - 1994年有17.5万次补骨脂素就诊，1995 - 1996年为6.1万次，1997 - 1998年为2.5万次（P =.0053）。在我们以大学为基础的医疗机构中，光疗就诊次数也出现了类似的下降。光疗的下降表明对银屑病一种安全有效的治疗方法的利用率降低。
